International Journal of Clinical and Experimental Medical Sciences

Volume 5, Issue 6, November 2019

  • FLT3-ITD Negative Refractory/Relapsed or Geratic AML Patients Responded Well to Salvage Treatment with Low Dose Cytarabine and Sorafenib

    Xu Jianhui, Yao Qianqian, Zhong Yuxia, He Yingzhi, Du Jingwen, Liu Minhong, Huang Yuxian, Li Yuhua, Wu Bingyi

    Issue: Volume 5, Issue 6, November 2019
    Pages: 92-97
    Received: 23 October 2019
    Accepted: 23 November 2019
    Published: 2 December 2019
    Abstract: There are great needs to explore more efficient and low-cytotoxic treatment for refractory/relapsed (R/R) or old acute myeloid leukemia (AML) patients without FLT3-ITD mutation. We observed the procedures and outcomes of 13 such patients subsequently treated by sorafenib in our departments. Five of them used low-dose cytorabine concomitantly and 8 ... Show More